Second, the cycling recommendation, 8-12 weeks on followed by a 4-week off period, is based on the general principle applied to peptide therapies to prevent receptor desensitization and to allow assessment of lasting effects, rather than on direct MOTS-c cycling data
GLP-3 (Reta) Mechanism of Action Acts as an agonist at three receptors the GIP receptor, the GLP-1 receptor, and the glucagon receptor the defining "triple agonist" pharmacology that separates it from single- and dual-incretin compounds
SIRT1 activation improves insulin sensitivity, promotes mitochondrial biogenesis via PGC-1alpha, and enhances autophagy
BPC-157: Science-backed uses, benefits, dosage, and safety
What are Antioxidants
1 2 3 "Diagnostic difficulties in pernicious anemia"